Terremoto Biosciences Funding: $250M Raised, Series B (2023)
Terremoto Biosciences is a Biotech company based in South San Francisco, CA. It has raised $250M in total funding. Latest round: Series B.
Terremoto Biosciences funding overview
Terremoto Biosciences is a Biotech company based in South San Francisco, CA. Terremoto Biosciences has raised $250M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in November 2023. The round record for Terremoto Biosciences runs through 2023; nothing later has been disclosed. Investors on record include EcoR1 Capital, Novo Holdings, Cormorant Capital, OrbiMed, Third Rock Ventures. 5 distinct backers are named across the disclosed rounds.
Terremoto Biosciences at a glance
Total raised
$250M
Latest round
Series B
Latest round date
November 2023
Industry
Biotech
Headquarters
South San Francisco, CA
Notable investors
EcoR1 Capital, Novo Holdings, Cormorant Capital, OrbiMed, Third Rock Ventures
Frequently asked about Terremoto Biosciences funding
How much has Terremoto Biosciences raised?
Terremoto Biosciences has raised $250M in total disclosed funding across the rounds on record.
Who has invested in Terremoto Biosciences?
EcoR1 Capital, Novo Holdings, Cormorant Capital, OrbiMed, Third Rock Ventures are named among the investors backing Terremoto Biosciences.
What was the latest Terremoto Biosciences funding round?
The most recent disclosed round is a Series B, announced in November 2023.
Where is Terremoto Biosciences based?
Terremoto Biosciences is based in South San Francisco, CA.
What sector does Terremoto Biosciences operate in?
Terremoto Biosciences is tracked under Biotech from South San Francisco, CA, with $250M in disclosed funding.
When did Terremoto Biosciences last raise?
The last disclosed Terremoto Biosciences round closed in November 2023 at Series B.
Terremoto Biosciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in South San Francisco below to benchmark round size and investor mix.
